Loading...
Projects / Programmes source: ARIS

Detection of molecular alterations during head and neck carcinogenesis

Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   

Code Science Field
B200  Biomedical sciences  Cytology, oncology, cancerology 
B520  Biomedical sciences  General pathology, pathological anatomy 
Keywords
Carcinogenesis, premalignant lesions, head and neck cancer, histology, immunohistochemistry, molecular pathology
Evaluation (rules)
source: COBISS
Researchers (14)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  17954  Mojca Bekanovič    Researcher  1999 
2.  17952  Tomo Brezovar    Researcher  1997 - 1999 
3.  05367  PhD Anton Cerar  Oncology  Researcher  1999  194 
4.  17953  Magdalena Dimnik    Researcher  1998 - 1999 
5.  02273  PhD Dušan Ferluga  Microbiology and immunology  Researcher  1999  531 
6.  07479  PhD Janez Fischinger  Oncology  Researcher  1997 - 1999  86 
7.  02127  PhD Nina Gale  Oncology  Head  1997 - 1999  406 
8.  09275  PhD Damjan Glavač  Chemistry  Researcher  1999  565 
9.  15472  PhD Boštjan Luzar  Oncology  Researcher  1999  459 
10.  17951  Albina Stančić    Researcher  1998 - 1999 
11.  17956  Olga Staniša    Researcher  1997 - 1999  15 
12.  18362  Daniel Velkavrh    Researcher  1998 - 1999 
13.  15471  Aleksandar Vodovnik  Microbiology and immunology  Researcher  1999  30 
14.  12955  PhD Nina Zidar  Microbiology and immunology  Researcher  1999  391 
Organisations (2)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  77,953 
2.  0381  University of Ljubljana, Faculty of Medicine  Ljubljana  1627066  48,742 
Abstract
The aim of our research is to define those phenotypical so as genetic characteristics of the squamous epithelium within the head and neck region, and particularly of the larynx, which manifest themselves as mutant proteins, numerical chromosome aberrations or gene mutations. Analysis of a large cohort of retrospectively and prospectively ascertained patients and their follow-up is expected to reveal reliable biomarkers important also for identification of high risk precancerous lesions that may progress to invasive cancer.
Views history
Favourite